- Home
- TARA vs ATLX Comparison
TARA vs ATLX Comparison
Compare TARA & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- ATLX
- Stock Information
- Founded
- TARA N/A
- ATLX 2011
- Country
- TARA United States
- ATLX Brazil
- Employees
- TARA N/A
- ATLX N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- TARA Health Care
- ATLX Industrials
- Exchange
- TARA Nasdaq
- ATLX Nasdaq
- Market Cap
- TARA 118.1M
- ATLX 111.7M
- IPO Year
- TARA N/A
- ATLX N/A
- Fundamental
- Price
- TARA $5.02
- ATLX $6.00
- Analyst Decision
- TARA Strong Buy
- ATLX Strong Buy
- Analyst Count
- TARA 6
- ATLX 1
- Target Price
- TARA $19.80
- ATLX $19.00
- AVG Volume (30 Days)
- TARA 723.1K
- ATLX 864.5K
- Earning Date
- TARA 11-11-2025
- ATLX 11-07-2025
- Dividend Yield
- TARA N/A
- ATLX N/A
- EPS Growth
- TARA N/A
- ATLX N/A
- EPS
- TARA N/A
- ATLX N/A
- Revenue
- TARA N/A
- ATLX $350,003.00
- Revenue This Year
- TARA N/A
- ATLX $22,084.55
- Revenue Next Year
- TARA N/A
- ATLX N/A
- P/E Ratio
- TARA N/A
- ATLX N/A
- Revenue Growth
- TARA N/A
- ATLX N/A
- 52 Week Low
- TARA $1.60
- ATLX $3.54
- 52 Week High
- TARA $10.48
- ATLX $11.89
- Technical
- Relative Strength Index (RSI)
- TARA 74.50
- ATLX 60.86
- Support Level
- TARA $4.81
- ATLX $5.78
- Resistance Level
- TARA $5.12
- ATLX $6.45
- Average True Range (ATR)
- TARA 0.35
- ATLX 0.49
- MACD
- TARA 0.10
- ATLX 0.15
- Stochastic Oscillator
- TARA 86.70
- ATLX 78.73
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.